Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| basal cell | 13 studies | 28% ± 11% | |
| retinal rod cell | 9 studies | 34% ± 18% | |
| fibroblast | 8 studies | 30% ± 11% | |
| smooth muscle cell | 5 studies | 19% ± 4% | |
| connective tissue cell | 4 studies | 27% ± 9% | |
| epithelial cell | 4 studies | 35% ± 20% | |
| retinal cone cell | 4 studies | 52% ± 22% | |
| secretory cell | 3 studies | 29% ± 12% | |
| renal alpha-intercalated cell | 3 studies | 30% ± 10% | |
| retinal bipolar neuron | 3 studies | 33% ± 3% | |
| mesothelial cell | 3 studies | 32% ± 11% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| eye | 7 studies | 29% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 2621.79 | 652 / 653 | 93% | 96.36 | 562 / 605 |
| uterus | 97% | 1258.99 | 165 / 170 | 95% | 88.87 | 434 / 459 |
| liver | 100% | 1999.78 | 226 / 226 | 88% | 55.53 | 359 / 406 |
| ovary | 81% | 655.69 | 145 / 180 | 96% | 60.34 | 411 / 430 |
| lung | 97% | 1124.78 | 561 / 578 | 70% | 46.72 | 807 / 1155 |
| bladder | 100% | 1414.29 | 21 / 21 | 67% | 48.03 | 337 / 504 |
| esophagus | 100% | 2746.17 | 1444 / 1445 | 58% | 32.73 | 107 / 183 |
| skin | 100% | 2307.16 | 1807 / 1809 | 57% | 15.21 | 267 / 472 |
| kidney | 100% | 1834.34 | 89 / 89 | 53% | 24.04 | 478 / 901 |
| brain | 64% | 519.47 | 1697 / 2642 | 76% | 20.11 | 534 / 705 |
| breast | 81% | 496.47 | 373 / 459 | 57% | 14.35 | 633 / 1118 |
| prostate | 93% | 804.60 | 227 / 245 | 43% | 9.90 | 216 / 502 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.28 | 1 / 1 |
| spleen | 97% | 1179.29 | 233 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 34% | 160.93 | 89 / 258 | 62% | 18.25 | 142 / 230 |
| adipose | 89% | 957.93 | 1075 / 1204 | 0% | 0 | 0 / 0 |
| intestine | 76% | 1218.91 | 733 / 966 | 12% | 3.75 | 62 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 87% | 63.76 | 39 / 45 |
| blood vessel | 78% | 531.62 | 1046 / 1335 | 0% | 0 | 0 / 0 |
| pancreas | 1% | 3.92 | 3 / 328 | 76% | 26.49 | 136 / 178 |
| heart | 67% | 423.28 | 577 / 861 | 0% | 0 | 0 / 0 |
| stomach | 40% | 416.65 | 144 / 359 | 10% | 2.56 | 29 / 286 |
| eye | 0% | 0 | 0 / 0 | 41% | 6.80 | 33 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 10% | 2.38 | 3 / 29 |
| muscle | 2% | 7.49 | 14 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 1% | 4.22 | 7 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016192 | Biological process | vesicle-mediated transport |
| GO_0006886 | Biological process | intracellular protein transport |
| GO_0009306 | Biological process | protein secretion |
| GO_0005730 | Cellular component | nucleolus |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005525 | Molecular function | GTP binding |
| GO_0003924 | Molecular function | GTPase activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ARL4D |
| Protein name | ADP-ribosylation factor-like protein 4D (ADP-ribosylation factor-like protein 4L) |
| Synonyms | ARF4L |
| Description | FUNCTION: Small GTP-binding protein which cycles between an inactive GDP-bound and an active GTP-bound form, and the rate of cycling is regulated by guanine nucleotide exchange factors (GEF) and GTPase-activating proteins (GAP). GTP-binding protein that does not act as an allosteric activator of the cholera toxin catalytic subunit. Recruits CYTH1, CYTH2, CYTH3 and CYTH4 to the plasma membrane in GDP-bound form. . |
| Accessions | P49703 ENST00000320033.5 |